by IR, NMR, mass spectral and elemental analyses. All the synthesized compounds 4(a-d), 5(a-d), 7(a-b), and 8(a-f) are evaluated for their in vitro DPPH scavenging, antimicrobial activity, in vivo analgesic, anti-inflammatory activities. The results of the anti-inflammatory activity are supported by molecular docking study with mouse COX-1 (PDB ID: 2CZT) and COX-2 (PDB ID: 3LN1) enzymes to predict their
新的2-(取代-苯基)乙酰
肼类似物系列,S-烷基化的5-取代的1,3,4-恶二唑-2-
硫酮衍
生物和5-亚芳基-3-取代的
1,2,4-三嗪合成得率很高,并通过IR,NMR,质谱和元素分析进行了表征。评价所有合成的化合物4(ad),5(ad),7(ab)和8(af)的体外
DPPH清除,抗微
生物活性,体内止痛,抗炎活性。抗炎活性的结果得到了与小鼠COX-1(PDB ID:2
CZT)和COX-2(PDB ID:3LN1)酶的分子对接研究的支持,以预测其假定的相互作用。在进行的所有测定中,化合物5-(4-
溴苯基)-3-(
萘-2-基甲基)-
1,2,4-三嗪(4d)和2-[5-(二苯甲基)-1,3,